Pfizer bought cancer biotech Seagen for $43 billion cash

Pfizer CEO paid $43 billion in cash for Seagen, which makes an innovative cancer treatment

Related Keywords

Bristol Myers Squibb , ,Pfizer ,Arena Pharmaceutical ,Trillium Therapeutics ,Astrazeneca ,Business ,Inance ,Health ,Medical ,Dharma ,Celgene ,Merck ,Life Sciences ,Pharmaceutical Industry ,Inlyta ,Articles ,Seagen ,Companies ,Uartz ,